Author information:
(1)David H. Koch Institute for Integrative Cancer Research, Massachusetts 
Institute of Technology, Cambridge, MA 02142, USA; Department of Biological 
Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; 
MIT Center for Precision Cancer Medicine, Massachusetts Institute of Technology, 
Cambridge, MA 02142, USA.
(2)Division of Oncology, Departments of Medicine and Pathology Stanford School 
of Medicine, Stanford, CA 94305, USA.
(3)David H. Koch Institute for Integrative Cancer Research, Massachusetts 
Institute of Technology, Cambridge, MA 02142, USA; Department of Biological 
Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
(4)Department of Molecular and Human Genetics and Verna & Marrs McLean 
Department of Biochemistry and Molecular Biology, Baylor College of Medicine, 
Houston, TX 77030, USA.
(5)David H. Koch Institute for Integrative Cancer Research, Massachusetts 
Institute of Technology, Cambridge, MA 02142, USA; Department of Biological 
Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; 
Kronos Bio, Inc., Cambridge, MA 02139, USA.
(6)Division of Hematology, Department of Medicine, Brigham and Women's Hospital, 
Harvard Medical School, Boston, MA 02115, USA; Department of Medical Oncology, 
Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and 
Harvard, Cambridge, MA 02142, USA.
(7)Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
(8)David H. Koch Institute for Integrative Cancer Research, Massachusetts 
Institute of Technology, Cambridge, MA 02142, USA; BioMicro Center, 
Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
(9)David H. Koch Institute for Integrative Cancer Research, Massachusetts 
Institute of Technology, Cambridge, MA 02142, USA.
(10)David H. Koch Institute for Integrative Cancer Research, Massachusetts 
Institute of Technology, Cambridge, MA 02142, USA; Department of Biological 
Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; 
Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, 
MA 02115, USA.
(11)Department of Molecular and Human Genetics and Verna & Marrs McLean 
Department of Biochemistry and Molecular Biology, Baylor College of Medicine, 
Houston, TX 77030, USA; Therapeutic Innovation Center, Baylor College of 
Medicine, Houston, TX 77030, USA.
(12)David H. Koch Institute for Integrative Cancer Research, Massachusetts 
Institute of Technology, Cambridge, MA 02142, USA; Department of Biological 
Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; 
MIT Center for Precision Cancer Medicine, Massachusetts Institute of Technology, 
Cambridge, MA 02142, USA; Broad Institute of MIT and Harvard, Cambridge, MA 
02142, USA. Electronic address: koehler@mit.edu.